Monopar Therapeutics Inc. (MNPR) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Monopar Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$73.39
+2.16% today
Market cap
$482M
Overall quality
—
Kronos AI 30-day
−5.3%
3 of 8 simulated paths end higher
Monopar Therapeutics Inc. (MNPR) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $482M. It trades at $73.39, up 2.16% today. 7 analysts' average target of $129.29 implies +76.2% from today's price. Kronos AI's 30-day forecast is −5.3% (3 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $129.29 |
| Low – high | $119.00 – $145.00 |
| Analysts | 7 |
| Upside to average | +76.2% |
Kronos AI 30-day forecast
| Expected close | $68.03 (−5.3%) |
| Likely range | −13.8% … +9.9% |
| As of | 2026-10-27 |
3 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.